Literature DB >> 21527943

Phosphate, oxidative stress, and nuclear factor-κB activation in vascular calcification.

Ziyad Al-Aly1.   

Abstract

Phosphate-induced vascular calcification, characterized by induction of osteogenic programs, mineral vesicle release, and apoptosis, is prevalent in patients with kidney disease. Zhao et al. provide a mechanistic link between phosphate-induced calcification and increased mitochondrial membrane potential, increased mitochondrial reactive oxygen species, activation of the nuclear factor-κB pathway, and subsequent expression of osteogenic genes and vascular mineralization. This link clarifies the intracellular mechanism of vascular calcification and may allow exploration of antioxidants as therapeutic agents for vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527943     DOI: 10.1038/ki.2010.548

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.

Authors:  Benjamin Bowe; Yan Xie; Hong Xian; Tingting Li; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 8.237

2.  Hyperhomocysteinemia induces vascular calcification by activating the transcription factor RUNX2 via Krüppel-like factor 4 up-regulation in mice.

Authors:  Lili Zhu; Na Zhang; Ru Yan; Wenjuan Yang; Guangzhi Cong; Ning Yan; Wanrui Ma; Jianjun Hou; Libo Yang; Shaobin Jia
Journal:  J Biol Chem       Date:  2019-10-18       Impact factor: 5.157

3.  Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway.

Authors:  Xiaoyu Liu; An Chen; Qingchun Liang; Xiulin Yang; Qianqian Dong; Mingwei Fu; Siyi Wang; Yining Li; Yuanzhi Ye; Zirong Lan; Yanting Chen; Jing-Song Ou; Pingzhen Yang; Lihe Lu; Jianyun Yan
Journal:  Aging Cell       Date:  2021-05-09       Impact factor: 9.304

Review 4.  Hyperphosphatemia. The hidden killer in chronic kidney disease.

Authors:  Akram M Askar
Journal:  Saudi Med J       Date:  2015-01       Impact factor: 1.484

5.  Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.

Authors:  Soon-Youn Choi; Hye-Myung Ryu; Eun-Joo Oh; Ji-Young Choi; Jang-Hee Cho; Chan-Duck Kim; Yong-Lim Kim; Sun-Hee Park
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  High Mobility Group Box 1 Promotes Aortic Calcification in Chronic Kidney Disease via the Wnt/β-Catenin Pathway.

Authors:  Xiucai Jin; Shu Rong; Weijie Yuan; Lijie Gu; Jieshuang Jia; Ling Wang; Honglei Yu; Yifeng Zhuge
Journal:  Front Physiol       Date:  2018-06-05       Impact factor: 4.566

7.  Association between Metformin Use and Coronary Artery Calcification in Type 2 Diabetic Patients.

Authors:  Yi Lu; Yidong Wang; Ting Weng; Zexin Chen; Xiujuan Sun; Jia Wei; Zhejun Cai; Meixiang Xiang
Journal:  J Diabetes Res       Date:  2019-05-05       Impact factor: 4.011

8.  Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2.

Authors:  Cheng Wang; Wenjing Xu; Jie An; Minglu Liang; Yiqing Li; Fengxiao Zhang; Qiangsong Tong; Kai Huang
Journal:  Nat Commun       Date:  2019-03-13       Impact factor: 14.919

9.  Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients.

Authors:  Hongran Moon; Ho Jun Chin; Ki Young Na; Kwon Wook Joo; Yon Su Kim; Sejoong Kim; Seung Seok Han
Journal:  BMC Nephrol       Date:  2019-09-18       Impact factor: 2.388

10.  Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum.

Authors:  Mohammad J Hosen; Paul J Coucke; Olivier Le Saux; Anne De Paepe; Olivier M Vanakker
Journal:  Orphanet J Rare Dis       Date:  2014-04-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.